請用此 Handle URI 來引用此文件：
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/80687完整後設資料紀錄
| DC 欄位 | 值 | 語言 |
|---|---|---|
| dc.contributor.advisor | 楊銘欽(Ming-Chin Yang) | |
| dc.contributor.author | Chien-Hsun Lee | en |
| dc.contributor.author | 李建勳 | zh_TW |
| dc.date.accessioned | 2022-11-24T03:12:56Z | - |
| dc.date.available | 2021-11-03 | |
| dc.date.available | 2022-11-24T03:12:56Z | - |
| dc.date.copyright | 2021-11-03 | |
| dc.date.issued | 2021 | |
| dc.date.submitted | 2021-10-21 | |
| dc.identifier.citation | 行政院主計總處 107年家庭收支調查報告. (2018). 衛生福利部中央健康保險署 2020-2021全民健康保險年報. (2021). 中華民國108年國民醫療保健支出. (2021). 台灣癌症基金會. 部分負擔民眾願付價格調查報告. (2019). 江门市医疗保障局 如何计算医保报销金额？. (2020). Retrieved from http://www.jiangmen.gov.cn/jmybj/gkmlpt/content/2/2217/post_2217506.html#416. 国家医疗保障局 国家基本医疗保险、工伤保险和生育保险 药品目录. (2020). 財團法人癌症希望基金會. 我挺健保改革 健保顧我健康. (2020). 厚生労働省 高額療養費制度を利用される皆さまへ. (2018). 許涵智（2018）。中國大陸城鄉醫療保險差異比較研究。東吳大學東吳大學法學院法律學系。 Australian Government Department of Health The Australian health system. (2019). Retrieved from https://www.health.gov.au/about-us/the-australian-health-system. Busse, R., Blümel, M., Knieps, F., Bärnighausen, T. (2017). Statutory health insurance in Germany: a health system shaped by 135 years of solidarity, self-governance, and competition. Lancet, 390(10097), 882-897. doi: 10.1016/s0140-6736(17)31280-1 Chen, G. T., Chang, S. C., Chang, C. J. (2018). New Drug Reimbursement and Pricing Policy in Taiwan. Value Health Reg Issues, 15, 127-132. doi: 10.1016/j.vhri.2018.03.004 Federal Office of Public Health FOPH Cost sharing „Frequently Asked Questions“ (FAQ). (2020). Medicare Costs for Medicare drug coverage. (2021). Damrongplasit, K., Melnick, G. (2015). Funding, coverage, and access under Thailand's universal health insurance program: an update after ten years. Appl Health Econ Health Policy, 13(2), 157-166. doi: 10.1007/s40258-014-0148-z Derkacz, M., Chmiel-Perzyńska, I., Buczak-Stec, E., Pachuta, I., Kowal, A., Grywalska, E., . . . Kuszewski, K. (2011). Co-payment for public health care services-public opinion survey. Przegl Epidemiol, 65(2), 363-370. Dixit, S. K., Sambasivan, M. (2018). A review of the Australian healthcare system: A policy perspective. SAGE Open Med, 6, 2050312118769211. doi: 10.1177/2050312118769211 European Observatory on Health, S., Policies, Gerkens, S., Merkur, S. (2020). Belgium: health system review (Vol. 22). Copenhagen: World Health Organization. Regional Office for Europe. Gibson, T. B., Maclean, R. J., Chernew, M. E., Fendrick, A. M., Baigel, C. (2015). Value-based insurance design: benefits beyond cost and utilization. Am J Manag Care, 21(1), 32-35. González López-Valcárcel, B., Librero, J., García-Sempere, A., Peña, L. M., Bauer, S., Puig-Junoy, J., Sanfélix-Gimeno, G. (2017). Effect of cost sharing on adherence to evidence-based medications in patients with acute coronary syndrome. Heart, 103(14), 1082-1088. doi: 10.1136/heartjnl-2016-310610 Gourzoulidis, G., Kourlaba, G., Stafylas, P., Giamouzis, G., Parissis, J., Maniadakis, N. (2017). Association between copayment, medication adherence and outcomes in the management of patients with diabetes and heart failure. Health Policy, 121(4), 363-377. doi: 10.1016/j.healthpol.2017.02.008 Health Insurance and Review Assessment Guide to health insurance self-pay standards. (2020). Retrieved from https://www.hira.or.kr/dummy.do?pgmid=HIRAA030056020110. Huang, J. H., Tung, C. M. (2006). The effects of outpatient co-payment policy on healthcare usage by the elderly in Taiwan. Arch Gerontol Geriatr, 43(1), 101-116. doi: 10.1016/j.archger.2005.09.007 Hynd, A., Roughead, E. E., Preen, D. B., Glover, J., Bulsara, M., Semmens, J. (2008). The impact of co-payment increases on dispensings of government-subsidised medicines in Australia. Pharmacoepidemiol Drug Saf, 17(11), 1091-1099. doi: 10.1002/pds.1670 Kemenade, Y. W. v. (2018). Healthcare in Europe 2018- The finance and reimbursement systems of 11 European countries. Lee, J. L., Maciejewski, M., Raju, S., Shrank, W. H., Choudhry, N. K. (2013). Value-based insurance design: quality improvement but no cost savings. Health Aff (Millwood), 32(7), 1251-1257. doi: 10.1377/hlthaff.2012.0902 Liu, S. Z., Romeis, J. C. (2003). Assessing the effect of Taiwan's outpatient prescription drug copayment policy in the elderly. Med Care, 41(12), 1331-1342. doi: 10.1097/01.Mlr.0000100579.91550.C4 Maciejewski, M. L., Bryson, C. L., Perkins, M., Blough, D. K., Cunningham, F. E., Fortney, J. C., Liu, C. F. (2010). Increasing copayments and adherence to diabetes, hypertension, and hyperlipidemic medications. Am J Manag Care, 16(1), e20-34. Mann, B. S., Barnieh, L., Tang, K., Campbell, D. J., Clement, F., Hemmelgarn, B., Manns, B. J. (2014). Association between drug insurance cost sharing strategies and outcomes in patients with chronic diseases: a systematic review. PLoS One, 9(3), e89168. doi: 10.1371/journal.pone.0089168 Maté le Polain, M. F., Marc Koopmanschap, Irina Cleemput (2010). Drug reimbursement systems: international comparison and policy recommendations. In T. B. H. C. K. Centre (Ed.). The Government of British Columbia Medical Services Plan. (2021). Retrieved from https://www2.gov.bc.ca/gov/content/health/health-drug-coverage/msp. The Danish Medicines Agency Medication Reimbursement Limits. (2021). Retrieved from https://laegemiddelstyrelsen.dk/da/tilskud/beregn-dit-tilskud/tilskudsgraenser/. Department of Health and Social Care,UK The National Health Service Charges for Drugs and Appilances Amendment Regulations 2021. (2021). Park, E., Choi, S. (2020). Who Benefits from the Fixed Copayment of Medical and Pharmaceutical Expenditure among the Korean Elderly? Int J Environ Res Public Health, 17(21). doi: 10.3390/ijerph17218118 Australian Government Department of Health Pharmaceutical Benefits Scheme. (2021). Retrieved from https://www.servicesaustralia.gov.au/individuals/services/medicare/pharmaceutical-benefits-scheme. The New Zealand Ministry of Health Pharmaceutical co-payments. (2014). Retrieved from https://www.health.govt.nz/our-work/primary-health-care/primary-health-care-subsidies-and-services/pharmaceutical-co-payments. The Government of Canada Provincial and Territorial Public Drug Benefit Programs. (2021). Retrieved from https://www.canada.ca/en/health-canada/services/health-care-system/pharmaceuticals/access-insurance-coverage-prescription-medicines/provincial-territorial-public-drug-benefit-programs.html. Roosa Tikkanen, R. O., Elias Mossialos, Ana Djordjevic, George A. Wharton. (2020a). International Health Care System Profiles- Germany. Roosa Tikkanen, R. O., Elias Mossialos, Ana Djordjevic, George A. Wharton. (2020b). International Health Care System Profiles - Canada. Roosa Tikkanen, R. O., Elias Mossialos, Ana Djordjevic, George A. Wharton. (2020c). International Health Care System Profiles - France. Roosa Tikkanen, R. O., Elias Mossialos, Ana Djordjevic, George A. Wharton. (2020d). International Health Care System Profiles - Sweden. Sakamoto, H., Rahman, M., Nomura, S., Okamoto, E., Koike, S., Yasunaga, H., Ghaznavi, C. (2018). Japan health system review. New Delhi: World Health Organization. Regional Office for South-East Asia. Tambor, M., Pavlova, M., Rechel, B., Golinowska, S., Sowada, C., Groot, W. (2014). Willingness to pay for publicly financed health care services in Central and Eastern Europe: evidence from six countries based on a contingent valuation method. Soc Sci Med, 116, 193-201. doi: 10.1016/j.socscimed.2014.07.009 Wong, A., Goh, S. N., Sowa, P. M., Bauer, J. D. (2020). A narrative review of healthcare financing and reimbursement of nutritional support for patients in Singapore. Health Policy, 124(10), 1146-1154. doi: https://doi.org/10.1016/j.healthpol.2020.06.008 Yang, B.-m., Bae, E.-y., Kim, J. (2008). Economic Evaluation And Pharmaceutical Reimbursement Reform In South Korea’s National Health Insurance. Health Affairs, 27(1), 179-187. doi: 10.1377/hlthaff.27.1.179 | |
| dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/80687 | - |
| dc.description.abstract | 為了紓解全民健保財務壓力，2021年保險費率從4.69%調漲至5.17%，補充保費費率也連動調整，從1.91%漲至2.11%；此外，健保署也提出部分負擔改革構想，希望能挹注健保財源，其中也包括藥品部分負擔之改革，唯尚未調查民眾對這些改革之之意見。因此本計畫利用自擬結構式問卷，探討一般民眾對於健保藥品費用部份負擔方式之意見。資料蒐集方法為透過網路社群平台發送邀請，請20歲以上民眾上網填答此一匿名問卷，再利用統計軟體進行描述性統計、二變項分析、及複迴歸分析等方法，檢定自變項(包括社會人口學特徵與與民眾健康相關因素)與依變項(包括對藥品費用分攤方式接受度、部分負擔意願與部分負擔上限額度設定)之相關性。 研究結果顯示，民眾社會人口學特徵與與健康相關因素對於藥品部分負擔認同程度、藥品部分負擔付費意願與自費上限額度設定方式具相關性。在藥品部分負擔認同程度之調查上，發現原本就了解健保藥品部分負擔計算方式的台灣民眾僅有21.59%；逾五成民眾完全可以接受目前的健保的門診藥費部分負擔與健保門診藥費部分負擔每次需付200元的上限金額規定；有66.37%的民眾贊成與非常贊成提高目前健保門診藥費部分負擔的最高上限金額，其中又以較年輕、學歷較高、職業為醫療保健相關者、沒有慢性疾病與沒有領慢性疾病連續處方箋者較為支持。此外，超過半數民眾完全支持提高健保門診藥費負擔金額上限的目的是在於「讓民眾有成本意識，多拿藥就要多負擔，減少藥品浪費」及「讓新藥可以早一點納入健保」；顯示台灣民眾對於健保藥品部分負擔認同度高，且大多也接受未來健保藥品部分負擔相關政策改革。 | zh_TW |
| dc.description.provenance | Made available in DSpace on 2022-11-24T03:12:56Z (GMT). No. of bitstreams: 1 U0001-1810202121231500.pdf: 3911717 bytes, checksum: 0e2c663360d0490a5106a0a3049a05d6 (MD5) Previous issue date: 2021 | en |
| dc.description.tableofcontents | 國立臺灣大學碩士學位論文口試委員會審定書 I 致謝 II 中文摘要 III 英文摘要 IV 目錄 VI 圖目錄 VIII 表目錄 IX 第一章 緒論 1 第一節、 研究緣起與動機 1 第二節、目的 3 第三節、名詞定義 3 第二章 文獻回顧 4 第一節、 各國藥品費用分攤模式 4 第二節、 民眾對藥品費用分攤模式看法之實證研究 32 第三章 研究方法與材料 35 第一節、 研究架構 35 第二節 研究設計 36 第三節 研究假說 36 第四節 研究變項與操作型定義 36 第五節 資料來源與蒐集工具 46 第六節 資料處理與分析 46 第四章 結果 48 第一節 描述性分析 48 第二節 雙變項分析 57 第三節 多變項分析 104 第五章 討論 119 第一節 假說檢定結果 119 第二節 研究限制 122 第六章 結論與建議 124 第一節 結論 124 第二節 建議 125 參考文獻 128 附錄 131 附錄一、研究論理委員會通過證明 131 附錄二、問卷內容 132 | |
| dc.language.iso | zh-TW | |
| dc.subject | 全民健保 | zh_TW |
| dc.subject | 自費上限 | zh_TW |
| dc.subject | 藥品部分負擔 | zh_TW |
| dc.subject | co-payment upper limit | en |
| dc.subject | national health insurance | en |
| dc.subject | prescription drug co-payment | en |
| dc.title | 民眾對於健保藥品費用部分負擔方式之意見調查 | zh_TW |
| dc.title | A study on the opinion of the general public toward the models of cost sharing for medicines under the National Health Insurance | en |
| dc.date.schoolyear | 109-2 | |
| dc.description.degree | 碩士 | |
| dc.contributor.oralexamcommittee | 李玉春(Hsin-Tsai Liu),郭年真(Chih-Yang Tseng) | |
| dc.subject.keyword | 全民健保,藥品部分負擔,自費上限, | zh_TW |
| dc.subject.keyword | national health insurance,prescription drug co-payment,co-payment upper limit, | en |
| dc.relation.page | 138 | |
| dc.identifier.doi | 10.6342/NTU202103846 | |
| dc.rights.note | 同意授權(限校園內公開) | |
| dc.date.accepted | 2021-10-21 | |
| dc.contributor.author-college | 公共衛生學院 | zh_TW |
| dc.contributor.author-dept | 健康政策與管理研究所 | zh_TW |
| 顯示於系所單位： | 健康政策與管理研究所 | |
文件中的檔案：
| 檔案 | 大小 | 格式 | |
|---|---|---|---|
| U0001-1810202121231500.pdf 授權僅限NTU校內IP使用（校園外請利用VPN校外連線服務） | 3.82 MB | Adobe PDF |
系統中的文件，除了特別指名其著作權條款之外，均受到著作權保護，並且保留所有的權利。